EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment benefit with enoxaparin in unstable angina is greatest in patients at highest risk A multivariate analysis from TIMI 11 B



Treatment benefit with enoxaparin in unstable angina is greatest in patients at highest risk A multivariate analysis from TIMI 11 B



Journal of the American College of Cardiology 33(2 SUPPL A): 352A




(PDF 0-2 workdays service: $29.90)

Accession: 035980078

Download citation: RISBibTeXText



Related references

Treatment benefit of enoxaparin in unstable angina/non-Q-wave myocardial infarction is maintained at one year followup in TIMI 11B. Circulation 100(18 SUPPL ): I 497, Nov 2, 1999

TIMI Risk Score to predict 6-month mortality, recurrent cardiac events, and relative benefit of invasive vs conservative strategy in patients with unstable angina Results from TACTICS-TIMI 18. Journal of the American College of Cardiology 37(2 Supplement A): 335A-336A, February, 2001

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 100(15): 1602-1608, 1999

Superiority of enoxaparin over unfractionated heparin in unstable angina/non-Q-wave myocardial infarction occurs early in treatment Results from the TIMI 11B-ESSENCE meta-analysis. European Heart Journal 21(Abstract Supplement): 598, August-September, 2000

Decrease of total hemorrhage with reduced doses of enoxaparin in high risk unstable angina. ENHNFAI study. (Enoxaparin vs non-fractionated heparin in unstable angina). Preliminary report. Archivos de Cardiologia de Mexico 72(3): 209-219, 2002

Benefit of tirofiban among patients treated without coronary intervention Application of the TIMI Risk Score for unstable angina/non-ST elevation MI in PRISM-PLUS. Circulation 104(17 Supplement): II 782, October 23, 2001

Enoxaparin for unstable angina/non-Qwave myocardial infarction Meta-analysis of TIMI 11 B and ESSENCE. Journal of the American College of Cardiology 33(2 SUPPL A): 351A, 1999

Superiority of enoxaparin over unfractionated heparin in unstable angina occurs early in treatment Results from TIMI 11 B. Journal of the American College of Cardiology 33(2 SUPPL A): 352A, 1999

Role of enoxaparin in patients undergoing percutaneous revascularization in the setting of unstable angina A TIMI 11B substudy. European Heart Journal 20(ABSTR SUPPL ): 260, 1999

Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators. Journal of the American College of Cardiology 29(7): 1474-1482, 1997

Dose-ranging trial of enoxaparin for unstable angina: Results of TIMI 11A. Journal of the American College of Cardiology 29(7): 1474-1482, 1997

Dose ranging trial of enoxaparin for unstable angina Results of TIMI 11 A. Circulation 94(8 SUPPL ): I554, 1996

An integrated clinical approach to predicting the benefit of tirofiban Application of the TIMI Risk Score for unstable angina/non-ST elevation MI in PRISM-PLUS. Journal of the American College of Cardiology 37(2 Supplement A): 344A, February, 2001

TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction. American Journal of Medicine 120(11): 993-998, 2007

Enoxaparin for the acute and management of unstable angina/non-Q wave myocardial infarction Results of TIMI 11B. Circulation 98(17 SUPPL ): I504, Oct 27, 1998